Goldman Sachs Group INC Schedule 13G passive stakes

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 6.8% of Soren Acquisition Corp.'s Class A ordinary shares as of March 31, 2026.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 4.7% of Natural Resource Partners LP's common units.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 7.2% of Four Leaf Acquisition Corporation's Class A common stock as of March 31, 2026.

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 5.1% of Charlton Aria Acquisition Corporation's Class A ordinary shares as of March 31, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported beneficial ownership of 5.0% of Bold Eagle Acquisition Corp's Class A ordinary shares as of March 31, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a beneficial ownership of 1,729,986 Class A ordinary shares, representing 7.3% of the outstanding shares, in Activate Energy Acquisition.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a beneficial ownership stake of 6.8% in Iris Acquisition Corp II's Class A ordinary shares.

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have reported beneficial ownership of 5.1% of W&T Offshore, Inc.'s common stock as of March 31, 2026.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of 2.7% of Voyager Acquisition Corp's Class A ordinary shares as of March 31, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 5.5% of Seaport Therapeutics, Inc.'s voting common stock as of May 6, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, indicating beneficial ownership of 8.5% of Pinterest, Inc.'s Class A Common Stock as of March 31, 2026.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported beneficial ownership of 6.2% of Oaktree Acquisition Corp III Life Sciences' Class A ordinary shares as of March 31, 2026.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of 8,160,102.82 shares of NuScale Power Corp. Class A common stock, representing 2.6% of the class.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 5.1% of M EVO GBL Acquisition Corp II's Class A ordinary shares as of March 31, 2026.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 5.0% of Lafayette Acquisition Corp's ordinary shares as of March 31, 2026.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 3.1% of Jackson Acquisition Co II's Class A ordinary shares.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported beneficial ownership of 6.5% of Graf Global Corp.'s Class A ordinary shares.

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 6.2% of D. Boral Arc Acquisition I Corp.'s Class A ordinary shares as of March 31, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 6.1% of American Exceptionalism Acquisition Corp. A's Class A ordinary shares.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, disclosing a beneficial ownership stake of 6.2% in International Money Express, Inc.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 5.3% of Fortress Value Acquisition Corp. V's Class A ordinary shares.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a beneficial ownership stake of 6.4% in FG Imperii Acquisition Corp's Class A Ordinary Shares as of March 31, 2026.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of Energizer Holdings, Inc. common stock.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 5.3% of Delek US Holdings, Inc. common stock as of March 31, 2026.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting no beneficial ownership of Dayforce, Inc. common stock as of March 31, 2026.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 840,243 Class A Ordinary Shares of Churchill Capital Corp IX, representing 2.9% of the class.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 3.6% of Centurion Acquisition Corp.'s Class A Ordinary Shares as of March 31, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have disclosed a beneficial ownership of 6.3% of Cantaloupe, Inc.'s common stock as of March 31, 2026.

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 5.2% of Cal Redwood Acquisition Corp.'s Class A Ordinary Shares as of March 31, 2026.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a beneficial ownership of 5.3% of Amicus Therapeutics, Inc. common stock as of March 31, 2026.